stresscopin (RT-400) / Renova Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  stresscopin (RT-400) / Renova Therapeutics
    Journal:  Discovery of polypeptide ligand-receptor pairs based on their co-evolution. (Pubmed Central) -  Mar 2, 2021   
    Human stresscopin and stresscopin-related peptide, paralogous to CRH, were also identified based on the conserved signaling pathways...Although many ligands were predicted based on sequence signatures, ligands of shorter sequences have not been identified, together with many "orphan" receptors without known ligands. Future development of tools for predicting ligands and high throughput assays to identify ligand-receptor pairs based on ligand binding and/or signal transduction could advance hormone-based physiology and pathophysiology.
  • ||||||||||  stresscopin (RT-400) / Renova Therapeutics
    Journal:  Investigation of Thermophysical Properties of AW-2024-T3 Bare and Clad Aluminum Alloys. (Pubmed Central) -  Aug 1, 2020   
    Specific heat, thermal diffusivity, and dynamic module (storage and loss) tests were performed in the range of 50 to 500 °C, except for DMA ones (RT-400 °C)...Additionally, the DSC results for a few selected scan rates were analyzed by the Kissinger method to give activation energies for the precipitation of q' and S' metastable phases in the alloys. The apparent activation energy of the q' and S' phases corresponds to 137.1 ± 4.4 for the bare alloy and 131.0 ± 6.0 (exo) and 104.1 ± 2.1 (exo) (two peaks) for the clad alloy.